Matches in Nanopublications for { ?s ?p "[These results not only highlight the potential of a synergistic drug combination of allosteric PARP inhibitors with DNA-damaging agents in genomically unstable cancer cells (regardless of homologous recombination status), but also signify important applications of selective PARP-1 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion description "[These results not only highlight the potential of a synergistic drug combination of allosteric PARP inhibitors with DNA-damaging agents in genomically unstable cancer cells (regardless of homologous recombination status), but also signify important applications of selective PARP-1 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion description "[These results not only highlight the potential of a synergistic drug combination of allosteric PARP inhibitors with DNA-damaging agents in genomically unstable cancer cells (regardless of homologous recombination status), but also signify important applications of selective PARP-1 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_provenance.